・Sun Pharma reportedly faces competition from two global conglomerates for Organon. ・The Indian firm reportedly made a non-binding offer for Organon in January. ・Organon reported a debt of $8.64 ...

Organon & Co. (NYSE:OGN) has entered into a definitive agreement to be acquired by Sun Pharmaceutical Industries. The transaction will lead to Organon being delisted from the New York Stock Exchange ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Organon (OGN) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock. Over ...

Shareholders of Organon & Co (Symbol: OGN) looking to boost their income beyond the stock's 1.2% annualized dividend yield can sell the January 2028 covered call at the $10 strike and collect the ...

We recently compiled a list of the Best Medical Stocks To Buy Under $20. In this article, we are going to take a look at where Organon & Co. (NYSE:OGN) stands against the other best medical stocks ...

Looking ahead to 2030, our model projects OGN could trade at an average price of $27.37, with a potential range between $20.53 and $34.21. This represents a potential 104.8% return from today's price.

Organon & Co. (NYSE:OGN) is one of the 10 High-Flying Stocks With Double-Digit Returns. Organon bounced back by 30.93 percent on Friday to close at $11.26 apiece, as investors snapped up shares ...

Investors interested in Medical Services stocks are likely familiar with Organon (OGN) and Medpace (MEDP). But which of these two stocks offers value investors a better bang for their buck right now?